Effectiveness and Tolerability of Anlotinib Plus PD-1 Inhibitors for Patients with Previously Treated Metastatic Soft-Tissue Sarcoma

OBJECTIVE: This study was to investigate the effectiveness and tolerability of anlotinib plus PD-1 inhibitors for patients with previously treated metastatic soft tissue sarcoma (STS). METHODS: Patients with previously treated metastatic STS who were administered with anlotinib plus PD-1 inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xin, Xu, Jie, Xie, Lu, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527032/
https://www.ncbi.nlm.nih.gov/pubmed/36196372
http://dx.doi.org/10.2147/IJGM.S379269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527032/
https://www.ncbi.nlm.nih.gov/pubmed/36196372
http://dx.doi.org/10.2147/IJGM.S379269

Ejemplares similares